{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:40:05Z","timestamp":1751485205700,"version":"3.41.0"},"reference-count":26,"publisher":"International College of Surgeons","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:p>Sorafenib (Nexabar, Bayer, Berlin, Germany), one of multikinase inhibitors, can infrequently downstage advanced hepatocellular carcinoma (HCC). There are some reports that sorafenib in combination with other modalities, such as transcatheter arterial chemoembolization (TACE) or radiation therapy, could represent a bridge to surgery. We have observed a progressive HCC case with hepatic vein tumor thrombosis proceeding to the inferior vena cava (IVC-HVTT) convert to a state of feasible curative resection after a multidisciplinary treatment which included sorafenib. The patient underwent a successful resection in consequence of this therapy. A 45-year-old male with Hepatitis B Virus-associated chronic hepatitis was diagnosed as HCC with IVC-HVTT. To obtain oncological curative resection, we performed TACE, radiation therapy followed by administration of sorafenib (800 mg per day, total 72 g). The tumor including IVC-HVTT remarkably shrank, therefore, an extended posterior sectionectomy and total removal of the IVC-HVTT was successfully performed. The operation time was 736 minutes and the amount of intraoperative hemorrhage was 805 mL. No postoperative complication occurred. Adjuvant therapy with sorafenib was started four weeks after the operation and continued for 6 months (800 mg per day, total 144 g). The patient is alive without recurrence for about 4 years from the initial therapy. Multidisciplinary therapy including sorafenib, TACE, radiation, and hepatic resection may be an effective strategy to treat HCC patients with IVC-HVTT.<\/jats:p>","DOI":"10.9738\/intsurg-d-14-00133.1","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T14:32:12Z","timestamp":1432650732000},"page":"908-914","source":"Crossref","is-referenced-by-count":10,"title":["Recurrence-Free Survival of a Hepatocellular Carcinoma Patient With Tumor Thrombosis of the Inferior Vena Cava After Treatment With Sorafenib and Hepatic Resection"],"prefix":"10.9738","volume":"100","author":[{"given":"Kenichi","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Beppu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"},{"name":"Department of Multidisciplinary Treatment for Gastroenterological Cancer, Innovation Center for Translational Research, Kumamoto University Hospital, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohisa","family":"Okabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kastunori","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Nitta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Chikamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Ishiko","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kumamoto Rosai Hospital, Yatsusiro, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4721","reference":[{"issue":"6","key":"i0020-8868-100-5-908-b01","series-title":"J Gastrointestinal Surg","first-page":"855","article-title":"Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series","volume":"10","author":"Le Treut\n              YP,","year":"2006","unstructured":"Le Treut\n              YP, \n            \n              Hardwigsen\n              J, \n            \n              Ananian\n              P, \n            \n              Saisse\n              J, \n            \n              Gregoire\n              E, \n            \n              Richa\n              H\n            \n            et al\n          . Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series. J Gastrointestinal Surg2006;10(6):855\u2013862"},{"issue":"4","key":"i0020-8868-100-5-908-b02","series-title":"Cancer","first-page":"796","article-title":"Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey","volume":"101","author":"Ikai\n              I,","year":"2004","unstructured":"Ikai\n              I, \n            \n              Arii\n              S, \n            \n              Kojiro\n              M, \n            \n              Ichida\n              T, \n            \n              Makuuchi\n              M, \n            \n              Matsuyama\n              Y\n            \n            et al\n          . Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer2004;101(4):796\u2013802"},{"issue":"3","key":"i0020-8868-100-5-908-b03","series-title":"Forensic Sci Int","first-page":"215","article-title":"Sudden death from massive pulmonary tumor embolism due to hepatocellular carcinoma","volume":"108","author":"Chan\n              GS,","year":"2000","unstructured":"Chan\n              GS, \n            \n              Ng\n              WK, \n            \n              Ng\n              IO, \n            \n              Dickens\n              P.\n            \n          \n          Sudden death from massive pulmonary tumor embolism due to hepatocellular carcinoma. Forensic Sci Int2000;108(3):215\u2013221"},{"issue":"3","key":"i0020-8868-100-5-908-b04","series-title":"Ann Surg","first-page":"433","article-title":"Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy","volume":"227","author":"Ikai\n              I,","year":"1998","unstructured":"Ikai\n              I, \n            \n              Yamaoka\n              Y, \n            \n              Yamamoto\n              Y, \n            \n              Ozaki\n              N, \n            \n              Sakai\n              Y, \n            \n              Satoh\n              S\n            \n            et al\n          . Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg1998;227(3):433\u2013439"},{"issue":"3","key":"i0020-8868-100-5-908-b05","series-title":"Int Surg","first-page":"141","article-title":"Thrombectomy before hepatic resection for hepatocellular carcinoma with a tumor thrombus extending to the inferior vena cava","volume":"86","author":"Shirabe\n              K,","year":"2001","unstructured":"Shirabe\n              K, \n            \n              Shimada\n              M, \n            \n              Tsujita\n              E, \n            \n              Maehara\n              S, \n            \n              Yamashita\n              Y, \n            \n              Rikimaru\n              T\n            \n            et al\n          . Thrombectomy before hepatic resection for hepatocellular carcinoma with a tumor thrombus extending to the inferior vena cava. Int Surg2001;86(3):141\u2013143"},{"issue":"110\u2013111","key":"i0020-8868-100-5-908-b06","series-title":"Hepatogastroenterology","first-page":"1694","article-title":"Treatment outcomes of surgical resection for hepatocellular carcinoma with inferior vena cava invasion and\/or thrombosis","volume":"58","author":"Jung\n              H,","year":"2011","unstructured":"Jung\n              H, \n            \n              Lee\n              KU, \n            \n              Shin\n              WY, \n            \n              Ahn\n              H.\n            \n          \n          Treatment outcomes of surgical resection for hepatocellular carcinoma with inferior vena cava invasion and\/or thrombosis. Hepatogastroenterology2011;58(110\u2013111):1694\u20131699"},{"issue":"3","key":"i0020-8868-100-5-908-b07","series-title":"Surgery","first-page":"300","article-title":"Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases","volume":"131","author":"Fukuda\n              S,","year":"2002","unstructured":"Fukuda\n              S, \n            \n              Okuda\n              K, \n            \n              Imamura\n              M, \n            \n              Imamura\n              I, \n            \n              Eriguchi\n              N, \n            \n              Aoyagi\n              S.\n            \n          \n          Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery2002;131(3):300\u2013310"},{"issue":"3","key":"i0020-8868-100-5-908-b08","series-title":"Radiother Oncol","first-page":"266","article-title":"Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma","volume":"84","author":"Toya\n              R,","year":"2007","unstructured":"Toya\n              R, \n            \n              Murakami\n              R, \n            \n              Baba\n              Y, \n            \n              Nishimura\n              R, \n            \n              Morishita\n              S, \n            \n              Ikeda\n              O\n            \n            et al\n          . Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol2007;84(3):266\u2013271"},{"issue":"78","key":"i0020-8868-100-5-908-b09","series-title":"Hepatogastroenterology","first-page":"1779","article-title":"Efficacy of radiotherapy for PV and IVC tumor thrombosis in unresectable HCC","volume":"54","author":"Sugiyama\n              S,","year":"2007","unstructured":"Sugiyama\n              S, \n            \n              Beppu\n              T, \n            \n              Ishiko\n              T, \n            \n              Takahashi\n              M, \n            \n              Masuda\n              T, \n            \n              Hirata\n              T\n            \n            et al\n          . Efficacy of radiotherapy for PV and IVC tumor thrombosis in unresectable HCC. Hepatogastroenterology2007;54(78):1779\u20131782"},{"issue":"9","key":"i0020-8868-100-5-908-b10","series-title":"J Gastroenterol Hepatol","first-page":"922","article-title":"Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein","volume":"14","author":"Kashima\n              Y,","year":"1999","unstructured":"Kashima\n              Y, \n            \n              Miyazaki\n              M, \n            \n              Ito\n              H, \n            \n              Kaiho\n              T, \n            \n              Nakagawa\n              K, \n            \n              Ambiru\n              S\n            \n            et al\n          . Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol1999;14(9):922\u2013927"},{"issue":"4","key":"i0020-8868-100-5-908-b11","series-title":"N Engl J Med","first-page":"378","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet\n              JM,","year":"2008","unstructured":"Llovet\n              JM, \n            \n              Ricci\n              S, \n            \n              Mazzaferro\n              V, \n            \n              Hilgard\n              P, \n            \n              Gane\n              E, \n            \n              Blanc\n              JF\n            \n            et al\n          . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med2008;359(4):378\u2013390"},{"issue":"1","key":"i0020-8868-100-5-908-b12","series-title":"Lancet Oncol","first-page":"25","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng\n              AL,","year":"2009","unstructured":"Cheng\n              AL, \n            \n              Kang\n              YK, \n            \n              Chen\n              Z, \n            \n              Tsao\n              CJ, \n            \n              Qin\n              S, \n            \n              Kim\n              JS\n            \n            et al\n          . Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol2009;10(1):25\u201334"},{"issue":"5","key":"i0020-8868-100-5-908-b13","series-title":"World J Surg","first-page":"1034","article-title":"Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion","volume":"37","author":"Nitta\n              H,","year":"2013","unstructured":"Nitta\n              H, \n            \n              Beppu\n              T, \n            \n              Imai\n              K, \n            \n              Hayashi\n              H, \n            \n              Chikamoto\n              A, \n            \n              Baba\n              H.\n            \n          \n          Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion. World J Surg2013;37(5):1034\u20131042"},{"issue":"3","key":"i0020-8868-100-5-908-b14","series-title":"JNCI","first-page":"205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse\n              P,","year":"2000","unstructured":"Therasse\n              P, \n            \n              Arbuck\n              SG, \n            \n              Eisenhauer\n              EA, \n            \n              Wanders\n              J, \n            \n              Kaplan\n              RS, \n            \n              Rubinstein\n              L\n            \n            et al\n          . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. JNCI2000;92(3):205\u2013216"},{"issue":"7","key":"i0020-8868-100-5-908-b15","series-title":"J Gastroenterol","first-page":"938","article-title":"Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system","volume":"46","author":"Beppu\n              T,","year":"2011","unstructured":"Beppu\n              T, \n            \n              Hayashi\n              H, \n            \n              Okabe\n              H, \n            \n              Masuda\n              T, \n            \n              Mima\n              K, \n            \n              Otao\n              R\n            \n            et al\n          . Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol2011;46(7):938\u2013943"},{"issue":"114","key":"i0020-8868-100-5-908-b16","series-title":"Hepatogastroenterology","first-page":"542","article-title":"Liver hanging maneuver decreases blood loss and operative time in a right-side hepatectomy","volume":"59","author":"Beppu\n              T,","year":"2012","unstructured":"Beppu\n              T, \n            \n              Ishiko\n              T, \n            \n              Chikamoto\n              A, \n            \n              Komori\n              H, \n            \n              Masuda\n              T, \n            \n              Hayashi\n              H\n            \n            et al\n          . Liver hanging maneuver decreases blood loss and operative time in a right-side hepatectomy. Hepatogastroenterology2012;59(114):542\u2013545"},{"issue":"11","key":"i0020-8868-100-5-908-b17","series-title":"Hepatogastroenterology","first-page":"1172","article-title":"Extension of surgical indication for advanced hepatocellular carcinoma: is it possible to prolong life span or improve quality of life?","volume":"43","author":"Tanaka\n              A,","year":"1996","unstructured":"Tanaka\n              A, \n            \n              Morimoto\n              T, \n            \n              Ozaki\n              N, \n            \n              Ikai\n              I, \n            \n              Yamamoto\n              Y, \n            \n              Tsunekawa\n              S\n            \n            et al\n          . Extension of surgical indication for advanced hepatocellular carcinoma: is it possible to prolong life span or improve quality of life?Hepatogastroenterology1996;43(11):1172\u20131181"},{"issue":"27","key":"i0020-8868-100-5-908-b18","series-title":"Hepatogastroenterology","first-page":"1862","article-title":"Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures","volume":"46","author":"Asahara\n              T,","year":"1999","unstructured":"Asahara\n              T, \n            \n              Itamoto\n              T, \n            \n              Katayama\n              K, \n            \n              Nakahara\n              H, \n            \n              Hino\n              H, \n            \n              Yano\n              M\n            \n            et al\n          . Hepatic resection with tumor thrombectomy for hepatocellular carcinoma with tumor thrombi in the major vasculatures. Hepatogastroenterology1999;46(27):1862\u20131869"},{"issue":"15","key":"i0020-8868-100-5-908-b19","series-title":"Hepatogastroenterology","first-page":"798","article-title":"Hepatic resection for hepatocellular carcinoma with a tumor thrombus extending to inferior vena cava","volume":"44","author":"Nonami\n              T,","year":"1997","unstructured":"Nonami\n              T, \n            \n              Nakao\n              A, \n            \n              Harada\n              A, \n            \n              Kaneko\n              T, \n            \n              Kurokawa\n              T, \n            \n              Takagi\n              H.\n            \n          \n          Hepatic resection for hepatocellular carcinoma with a tumor thrombus extending to inferior vena cava. Hepatogastroenterology1997;44(15):798\u2013802"},{"issue":"2","key":"i0020-8868-100-5-908-b20","series-title":"Int J Radiat Oncol Biol Phys","first-page":"362","article-title":"Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion","volume":"84","author":"Hou\n              JZ,","year":"2012","unstructured":"Hou\n              JZ, \n            \n              Zeng\n              ZC, \n            \n              Zhang\n              JY, \n            \n              Fan\n              J, \n            \n              Zhou\n              J, \n            \n              Zeng\n              MS.\n            \n          \n          Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys2012;84(2):362\u2013368"},{"key":"i0020-8868-100-5-908-b21","series-title":"Int J Hepatol","first-page":"791013","article-title":"Liver resection after downstaging hepatocellular carcinoma with sorafenib","volume":"2011","author":"Barbier\n              L,","year":"2011","unstructured":"Barbier\n              L, \n            \n              Muscari\n              F, \n            \n              Le Guellec\n              S, \n            \n              Pariente\n              A, \n            \n              Otal\n              P, \n            \n              Suc\n              B.\n            \n          \n          Liver resection after downstaging hepatocellular carcinoma with sorafenib. Int J Hepatol2011;2011:791013"},{"issue":"5","key":"i0020-8868-100-5-908-b22","series-title":"Liver Int","first-page":"740","article-title":"Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection","volume":"31","author":"Irtan\n              S,","year":"2011","unstructured":"Irtan\n              S, \n            \n              Chopin-Laly\n              X, \n            \n              Ronot\n              M, \n            \n              Faivre\n              S, \n            \n              Paradis\n              V, \n            \n              Belghiti\n              J.\n            \n          \n          Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection. Liver Int2011;31(5):740\u2013743"},{"issue":"12","key":"i0020-8868-100-5-908-b23","series-title":"J Clin Oncol","first-page":"e330","article-title":"Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report","volume":"29","author":"Curtit\n              E,","year":"2011","unstructured":"Curtit\n              E, \n            \n              Thiery-Vuillemin\n              A, \n            \n              Nguyen\n              T, \n          Heyd B, Pivot X, Martino V. Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report. J Clin Oncol2011;29(12):e330\u2013332"},{"key":"i0020-8868-100-5-908-b24","series-title":"Oncology","first-page":"154\u2013","article-title":"Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.","volume":"78(suppl 1):","author":"Kudo\n              M,","year":"2010","unstructured":"Kudo\n              M, \n            \n              Ueshima\n              K.\n            \n          \n          Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.\n          Oncology\n          2010;78(suppl 1):154\u2013166"},{"issue":"4","key":"i0020-8868-100-5-908-b25","series-title":"Curr Oncol","first-page":"257","article-title":"Management of hepatocellular carcinoma: beyond sorafenib","volume":"14","author":"Chan\n              SL,","year":"2012","unstructured":"Chan\n              SL, \n            \n              Mok\n              T, \n            \n              Ma\n              BB.\n            \n          \n          Management of hepatocellular carcinoma: beyond sorafenib. Curr Oncol2012;14(4):257\u2013266"},{"issue":"4","key":"i0020-8868-100-5-908-b26","series-title":"J Dig Dis","first-page":"181","article-title":"Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study","volume":"14","author":"Bai\n              W,","year":"2013","unstructured":"Bai\n              W, \n            \n              Wang\n              YJ, \n            \n              Zhao\n              Y, \n            \n              Qi\n              XS, \n            \n              Yin\n              ZX, \n            \n              He\n              CY\n            \n            et al\n          . Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study. J Dig Dis2013;14(4):181\u2013190"}],"container-title":["International Surgery"],"original-title":[],"link":[{"URL":"https:\/\/international-surgery.kglmeridian.com\/view\/journals\/insu\/100\/5\/article-p908.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/international-surgery\/article-pdf\/100\/5\/908\/2207282\/intsurg-d-14-00133_1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/international-surgery.kglmeridian.com\/downloadpdf\/journals\/insu\/100\/5\/article-p908.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/international-surgery.kglmeridian.com\/downloadpdf\/journals\/insu\/100\/5\/article-p908.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:00:14Z","timestamp":1751482814000},"score":1,"resource":{"primary":{"URL":"https:\/\/international-surgery.kglmeridian.com\/view\/journals\/insu\/100\/5\/article-p908.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":26,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.9738\/intsurg-d-14-00133.1","relation":{},"ISSN":["0020-8868","2520-2456"],"issn-type":[{"type":"print","value":"0020-8868"},{"type":"electronic","value":"2520-2456"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}